1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update

Summary

OPKO Health, Inc. (OPKO), formerly eXegenics, Inc., is a biopharmaceutical and diagnostic company. It discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (“LDTs”), molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It offers products and vaccines that are used in the treatment of chronic kidney disease, Parkinson’s disease, asthma, hemophilia, obesity, chronic obstructive pulmonary disease (COPD) and chemotherapy-induced nausea and vomiting, among others. The company has its operational presence with its offices located in Chile, Mexico, Spain, Ireland, Canada, Brazil and Israel. OPKO is headquartered in Miami, Florida, the US.The company focuses on expanding its products into mew medical markets, which provides significant opportunities and complement its business. In line with this the company launched its 4Kscore test in Mexico through its wholly owned subsidiary, OPKO Health Mexico.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company OPKO Health, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update
Table of Contents
Table of Contents 2
List of Tables 4
List of Figuress 6
OPKO Health, Inc. Company Snapshot 7
OPKO Health, Inc. Company Overview 7
Key Information 7
OPKO Health, Inc. Pipeline Products and Clinical Trials Overview 8
OPKO Health, Inc. - Pipeline Analysis Overview 11
Business Description 11
Key Facts 11
OPKO Health, Inc. - Major Products and Services 12
OPKO Health, Inc. Pipeline Products by Development Stage 13
OPKO Health, Inc. Pipeline Products Overview 16
4KScore Biomarker Panel - POC Version Prostate Cancer Test 16
4KScore Biomarker Panel - POC Version Prostate Cancer Test Product Overview 16
Aquashunt 17
Aquashunt Product Overview 17
BMS Diagnostic Test - Alzheimer's Disease 18
BMS Diagnostic Test - Alzheimer's Disease Product Overview 18
Claros 1 - Vitamin D Test 19
Claros 1 - Vitamin D Test Product Overview 19
Diagnostic Assay - BNP 20
Diagnostic Assay - BNP Product Overview 20
Diagnostic Assay - CTnl 21
Diagnostic Assay - CTnl Product Overview 21
Diagnostic Assay - D-dimer 22
Diagnostic Assay - D-dimer Product Overview 22
Diagnostic Assay - Folic Acid 23
Diagnostic Assay - Folic Acid Product Overview 23
Diagnostic Assay - HBV 24
Diagnostic Assay - HBV Product Overview 24
Diagnostic Assay - HIV 25
Diagnostic Assay - HIV Product Overview 25
Diagnostic Assay - Lyme Disease 26
Diagnostic Assay - Lyme Disease Product Overview 26
Diagnostic Assay - Menopause 27
Diagnostic Assay - Menopause Product Overview 27
Diagnostic Assay - Pre-term Bleed 28
Diagnostic Assay - Pre-term Bleed Product Overview 28
Diagnostic Assay - Syphilis 29
Diagnostic Assay - Syphilis Product Overview 29
Diagnostic Assay - TSH 30
Diagnostic Assay - TSH Product Overview 30
Diagnostic Assay - Fertility 31
Diagnostic Assay - Fertility Product Overview 31
Diagnostic Test - Alzheimer's Disease 32
Diagnostic Test - Alzheimer's Disease Product Overview 32
Diagnostic Test - Diabetes 33
Diagnostic Test - Diabetes Product Overview 33
Diagnostic Test - Multiple Sclerosis 34
Diagnostic Test - Multiple Sclerosis Product Overview 34
Diagnostic Test - Non-Small Cell Lung Cancer 35
Diagnostic Test - Non-Small Cell Lung Cancer Product Overview 35
Diagnostic Test - Pancreatic Cancer 36
Diagnostic Test - Pancreatic Cancer Product Overview 36
Diagnostic Test - Parkinson's Disease 37
Diagnostic Test - Parkinson's Disease Product Overview 37
Diagnostic Test - Tuberculosis 38
Diagnostic Test - Tuberculosis Product Overview 38
Inspiromatic 39
Inspiromatic Product Overview 39
OPKO Sangia - Testosterone Assay 40
OPKO Sangia - Testosterone Assay Product Overview 40
OPKO Sangia - Total PSA Test 41
OPKO Sangia - Total PSA Test Product Overview 41
Point-Of-Care System 42
Point-Of-Care System Product Overview 42
Testosterone Diagnostic Assay - CLIA-Waiver 43
Testosterone Diagnostic Assay - CLIA-Waiver Product Overview 43
OPKO Health, Inc. - Key Competitors 44
OPKO Health, Inc. - Key Employees 45
OPKO Health, Inc. - Key Employee Biographies 46
OPKO Health, Inc. - Locations And Subsidiaries 47
Head Office 47
Other Locations and Subsidiaries 47
Recent Developments 49
OPKO Health, Inc., Recent Developments 49
Mar 18, 2015: OPKO Lab Receives Accreditation From College of American Pathologists 49
Feb 27, 2015: OPKO Announces Fourth Quarter Operating and Financial Results 49
Feb 20, 2015: OPKO Announces Publication of 20 Year Outcome Study for Lethal Prostate Cancer Using Kallikrein Biomarkers in 4Kscore Test 51
Jan 28, 2015: OPKO Launches the 4Kscore Test in Mexico 51
Nov 10, 2014: OPKO Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscoreâ„¢ Test for High Grade Prostate Cancer in the United States 52
Nov 07, 2014: OPKO Announces Third Quarter Operating and Financial Results 52
Sep 15, 2014: OPKO Launches the 4Kscore Test in Europe 54
Aug 11, 2014: OPKO Announces Second Quarter Operating and Financial Results 55
May 19, 2014: OPKO Presents 4Kscore Test Clinical Study at the American Urological Association Plenary Session 56
May 09, 2014: OPKO Announces First Quarter Operating Results 57
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59

List of Tables
OPKO Health, Inc., Key Facts 7
OPKO Health, Inc. Pipeline Products and Clinical Trials Overview 8
OPKO Health, Inc. Pipeline Products by Equipment Type 8
OPKO Health, Inc. Pipeline Products by Indication 10
OPKO Health, Inc., Key Facts 11
OPKO Health, Inc., Major Products and Services 12
OPKO Health, Inc. Number of Pipeline Products by Development Stage 13
OPKO Health, Inc. Pipeline Products Summary by Development Stage 14
4KScore Biomarker Panel - POC Version Prostate Cancer Test - Product Status 16
4KScore Biomarker Panel - POC Version Prostate Cancer Test - Product Description 16
Aquashunt - Product Status 17
Aquashunt - Product Description 17
BMS Diagnostic Test - Alzheimer's Disease - Product Status 18
BMS Diagnostic Test - Alzheimer's Disease - Product Description 18
Claros 1 - Vitamin D Test - Product Status 19
Claros 1 - Vitamin D Test - Product Description 19
Diagnostic Assay - BNP - Product Status 20
Diagnostic Assay - BNP - Product Description 20
Diagnostic Assay - CTnl - Product Status 21
Diagnostic Assay - CTnl - Product Description 21
Diagnostic Assay - D-dimer - Product Status 22
Diagnostic Assay - D-dimer - Product Description 22
Diagnostic Assay - Folic Acid - Product Status 23
Diagnostic Assay - Folic Acid - Product Description 23
Diagnostic Assay - HBV - Product Status 24
Diagnostic Assay - HBV - Product Description 24
Diagnostic Assay - HIV - Product Status 25
Diagnostic Assay - HIV - Product Description 25
Diagnostic Assay - Lyme Disease - Product Status 26
Diagnostic Assay - Lyme Disease - Product Description 26
Diagnostic Assay - Menopause - Product Status 27
Diagnostic Assay - Menopause - Product Description 27
Diagnostic Assay - Pre-term Bleed - Product Status 28
Diagnostic Assay - Pre-term Bleed - Product Description 28
Diagnostic Assay - Syphilis - Product Status 29
Diagnostic Assay - Syphilis - Product Description 29
Diagnostic Assay - TSH - Product Status 30
Diagnostic Assay - TSH - Product Description 30
Diagnostic Assay - Fertility - Product Status 31
Diagnostic Assay - Fertility - Product Description 31
Diagnostic Test - Alzheimer's Disease - Product Status 32
Diagnostic Test - Alzheimer's Disease - Product Description 32
Diagnostic Test - Diabetes - Product Status 33
Diagnostic Test - Diabetes - Product Description 33
Diagnostic Test - Multiple Sclerosis - Product Status 34
Diagnostic Test - Multiple Sclerosis - Product Description 34
Diagnostic Test - Non-Small Cell Lung Cancer - Product Status 35
Diagnostic Test - Non-Small Cell Lung Cancer - Product Description 35
Diagnostic Test - Pancreatic Cancer - Product Status 36
Diagnostic Test - Pancreatic Cancer - Product Description 36
Diagnostic Test - Parkinson's Disease - Product Status 37
Diagnostic Test - Parkinson's Disease - Product Description 37
Diagnostic Test - Tuberculosis - Product Status 38
Diagnostic Test - Tuberculosis - Product Description 38
Inspiromatic - Product Status 39
Inspiromatic - Product Description 39
OPKO Sangia - Testosterone Assay - Product Status 40
OPKO Sangia - Testosterone Assay - Product Description 40
OPKO Sangia - Total PSA Test - Product Status 41
OPKO Sangia - Total PSA Test - Product Description 41
Point-Of-Care System - Product Status 42
Point-Of-Care System - Product Description 42
Testosterone Diagnostic Assay - CLIA-Waiver - Product Status 43
Testosterone Diagnostic Assay - CLIA-Waiver - Product Description 43
OPKO Health, Inc., Key Employees 45
OPKO Health, Inc., Key Employee Biographies 46
OPKO Health, Inc., Subsidiaries 47

List of Figuress
OPKO Health, Inc. Pipeline Products by Equipment Type 9
OPKO Health, Inc. Pipeline Products by Development Stage 13

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Plasminogen Activator Inhibitor 1 (Endothelial ...

Proteinase Activated Receptor 2 (PAR2 or Coagulation Factor II Receptor Like 1 or G Protein Coupled Receptor 11 or Thrombin Receptor Like 1 or GPR11 or F2RL1) - Pipeline Review, H2 2016

Proteinase Activated Receptor 2 (PAR2 or Coagulation Factor II Receptor Like 1 or G Protein Coupled Receptor 11 or Thrombin Receptor Like 1 or GPR11 or F2RL1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Proteinase Activated Receptor 2 (PAR2 or Coagulation Factor II Receptor Like 1 or G Protein Coupled Receptor 11 or Thrombin Receptor Like 1 or GPR11 or F2RL1) - Pipeline Review, H2 2016 Summary Global ...

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Coagulation Factor XI (Plasma Thromboplastin Antecedent ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.